CORT
CORT
NASDAQ · Pharmaceuticals

Corcept Therapeutics Inc

$52.28
+1.23 (+2.41%)
As of May 9, 1:20 AM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 9 75%
Hold 3 25%
Sell 0 0%
Price Target
Analyst Price Target +95.7% upside
Low Target $62.31
Average Target $102.33
High Target $121.34
Current Price $52.28
Current
$52.28
Target
$102.33
$62.31 $102.33 avg $121.34
Scenario Analysis
Bear Case
$62.31
19.2%
Low target
Base Case
$102.33
+95.7%
Avg target
Bull Case
$121.34
+132.1%
High target
Risk/Reward
6.9x
Highly favorable
Price in Context
52-Week High
$91.00
-42.5% from high
52-Week Low
$28.66
+82.4% from low
50-Day SMA
$53.13
-1.6% vs SMA
200-Day SMA
$69.00
-24.2% vs SMA
RSI (14)
26.0
Oversold
Target vs 52W High
$102.33
+12.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 69% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 35 43% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%